No responsible menopause clinician should be prescribing it
Who Is a Candidate for TB-500 at Perfect B
6 The phase 2 monotherapy dose-finding trial by Lau and colleagues established that once-weekly cagrilintide up to 4.5 mg produced dose-dependent weight loss about 10.8% at the top dose over 26 weeks with a gastrointestinal side-effect profile (nausea and related symptoms) that is the clinical fingerprint of a gut-slowing, satiating mechanism
Combined with weight loss, improved body image, and normalized cycles, many women with PCOS report improved sexual satisfaction on semaglutide, even when the general population shows mixed results
Furthermore, it might have diminished the expression of urea cycle enzymes, possibly restored nitrogen balance, and, in theory, altered or improved nitrogen concentrations in different organs
Skipped periods A 2023 research review mentioned that losing 10%--15% of your body weight in a short period of time can cause amenorrhea , the medical term for missed periods
